nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—ABCB1—peripheral nervous system neoplasm	0.199	1	CbGaD
Haloperidol—CBR1—Doxorubicin—peripheral nervous system neoplasm	0.116	0.223	CbGbCtD
Haloperidol—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.0424	0.0812	CbGbCtD
Haloperidol—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0365	0.0698	CbGbCtD
Haloperidol—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0339	0.065	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0339	0.065	CbGbCtD
Haloperidol—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0254	0.0487	CbGbCtD
Haloperidol—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0204	0.039	CbGbCtD
Haloperidol—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0178	0.0341	CbGbCtD
Haloperidol—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0178	0.0341	CbGbCtD
Haloperidol—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0171	0.0327	CbGbCtD
Haloperidol—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0163	0.0312	CbGbCtD
Haloperidol—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0156	0.0298	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0156	0.0298	CbGbCtD
Haloperidol—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0123	0.0236	CbGbCtD
Haloperidol—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0117	0.0224	CbGbCtD
Haloperidol—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0107	0.0205	CbGbCtD
Haloperidol—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0107	0.0204	CbGbCtD
Haloperidol—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00992	0.019	CbGbCtD
Haloperidol—HTR1D—meninx—peripheral nervous system neoplasm	0.00882	0.116	CbGeAlD
Haloperidol—HTR1B—dura mater—peripheral nervous system neoplasm	0.00838	0.111	CbGeAlD
Haloperidol—HTR1D—dura mater—peripheral nervous system neoplasm	0.00811	0.107	CbGeAlD
Haloperidol—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00797	0.0153	CbGbCtD
Haloperidol—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0076	0.0146	CbGbCtD
Haloperidol—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00731	0.014	CbGbCtD
Haloperidol—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00709	0.0136	CbGbCtD
Haloperidol—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00697	0.0133	CbGbCtD
Haloperidol—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00475	0.0091	CbGbCtD
Haloperidol—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.00474	0.0625	CbGeAlD
Haloperidol—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00456	0.00873	CbGbCtD
Haloperidol—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00448	0.00858	CbGbCtD
Haloperidol—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00417	0.008	CbGbCtD
Haloperidol—HTR1B—trigeminal nerve—peripheral nervous system neoplasm	0.0036	0.0475	CbGeAlD
Haloperidol—HTR1D—trigeminal nerve—peripheral nervous system neoplasm	0.00349	0.046	CbGeAlD
Haloperidol—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00285	0.00545	CbGbCtD
Haloperidol—GRIN2B—nerve—peripheral nervous system neoplasm	0.00271	0.0357	CbGeAlD
Haloperidol—GRIN2B—ganglion—peripheral nervous system neoplasm	0.00267	0.0353	CbGeAlD
Haloperidol—HTR1B—cranial nerve—peripheral nervous system neoplasm	0.00257	0.0339	CbGeAlD
Haloperidol—HTR1D—cranial nerve—peripheral nervous system neoplasm	0.00249	0.0328	CbGeAlD
Haloperidol—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00173	0.0229	CbGeAlD
Haloperidol—DRD1—nerve—peripheral nervous system neoplasm	0.00162	0.0214	CbGeAlD
Haloperidol—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00162	0.0214	CbGeAlD
Haloperidol—DRD1—ganglion—peripheral nervous system neoplasm	0.0016	0.0212	CbGeAlD
Haloperidol—HTR1B—ganglion—peripheral nervous system neoplasm	0.0013	0.0171	CbGeAlD
Haloperidol—HTR1D—ganglion—peripheral nervous system neoplasm	0.00126	0.0166	CbGeAlD
Haloperidol—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00123	0.0163	CbGeAlD
Haloperidol—HTR2A—pons—peripheral nervous system neoplasm	0.00122	0.0161	CbGeAlD
Haloperidol—GRIN2B—brainstem—peripheral nervous system neoplasm	0.00116	0.0153	CbGeAlD
Haloperidol—CBR1—trigeminal ganglion—peripheral nervous system neoplasm	0.000974	0.0128	CbGeAlD
Haloperidol—DRD2—nerve—peripheral nervous system neoplasm	0.000959	0.0127	CbGeAlD
Haloperidol—DRD2—ganglion—peripheral nervous system neoplasm	0.000947	0.0125	CbGeAlD
Haloperidol—CBR1—parotid gland—peripheral nervous system neoplasm	0.000918	0.0121	CbGeAlD
Haloperidol—H1F0—trigeminal ganglion—peripheral nervous system neoplasm	0.000798	0.0105	CbGeAlD
Haloperidol—H1F0—parotid gland—peripheral nervous system neoplasm	0.000752	0.00993	CbGeAlD
Haloperidol—DRD1—brainstem—peripheral nervous system neoplasm	0.000697	0.0092	CbGeAlD
Haloperidol—HTR1B—trigeminal ganglion—peripheral nervous system neoplasm	0.000638	0.00842	CbGeAlD
Haloperidol—HTR2A—nerve—peripheral nervous system neoplasm	0.000633	0.00835	CbGeAlD
Haloperidol—HTR2A—ganglion—peripheral nervous system neoplasm	0.000625	0.00825	CbGeAlD
Haloperidol—HTR1D—trigeminal ganglion—peripheral nervous system neoplasm	0.000618	0.00815	CbGeAlD
Haloperidol—SIGMAR1—trigeminal ganglion—peripheral nervous system neoplasm	0.000576	0.0076	CbGeAlD
Haloperidol—GRIN2B—cerebellum—peripheral nervous system neoplasm	0.000573	0.00756	CbGeAlD
Haloperidol—HTR1B—brainstem—peripheral nervous system neoplasm	0.000565	0.00745	CbGeAlD
Haloperidol—HTR1D—brainstem—peripheral nervous system neoplasm	0.000547	0.00722	CbGeAlD
Haloperidol—SIGMAR1—parotid gland—peripheral nervous system neoplasm	0.000543	0.00717	CbGeAlD
Haloperidol—KCNH2—trigeminal ganglion—peripheral nervous system neoplasm	0.000459	0.00605	CbGeAlD
Haloperidol—CBR1—cerebellum—peripheral nervous system neoplasm	0.000425	0.0056	CbGeAlD
Haloperidol—DRD2—brainstem—peripheral nervous system neoplasm	0.000412	0.00543	CbGeAlD
Haloperidol—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.000368	0.00485	CbGeAlD
Haloperidol—CYP1A1—parotid gland—peripheral nervous system neoplasm	0.000365	0.00482	CbGeAlD
Haloperidol—H1F0—cerebellum—peripheral nervous system neoplasm	0.000348	0.00459	CbGeAlD
Haloperidol—HTR2A—brainstem—peripheral nervous system neoplasm	0.000272	0.00358	CbGeAlD
Haloperidol—SIGMAR1—cerebellum—peripheral nervous system neoplasm	0.000251	0.00332	CbGeAlD
Haloperidol—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000247	0.00327	CbGeAlD
Haloperidol—DRD2—cerebellum—peripheral nervous system neoplasm	0.000203	0.00268	CbGeAlD
Haloperidol—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000201	0.00265	CbGeAlD
Haloperidol—KCNH2—cerebellum—peripheral nervous system neoplasm	0.0002	0.00264	CbGeAlD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000157	0.000977	CcSEcCtD
Haloperidol—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000156	0.000974	CcSEcCtD
Haloperidol—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000156	0.000973	CcSEcCtD
Haloperidol—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000966	CcSEcCtD
Haloperidol—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000155	0.000966	CcSEcCtD
Haloperidol—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000155	0.000966	CcSEcCtD
Haloperidol—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000155	0.000965	CcSEcCtD
Haloperidol—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000154	0.000962	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000153	0.000955	CcSEcCtD
Haloperidol—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000951	CcSEcCtD
Haloperidol—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000152	0.000951	CcSEcCtD
Haloperidol—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000152	0.000947	CcSEcCtD
Haloperidol—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000152	0.000946	CcSEcCtD
Haloperidol—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000151	0.000944	CcSEcCtD
Haloperidol—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000151	0.000943	CcSEcCtD
Haloperidol—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000151	0.000943	CcSEcCtD
Haloperidol—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000937	CcSEcCtD
Haloperidol—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00015	0.000936	CcSEcCtD
Haloperidol—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000934	CcSEcCtD
Haloperidol—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.00093	CcSEcCtD
Haloperidol—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000149	0.000928	CcSEcCtD
Haloperidol—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000149	0.000928	CcSEcCtD
Haloperidol—Rash—Topotecan—peripheral nervous system neoplasm	0.000149	0.000928	CcSEcCtD
Haloperidol—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000149	0.000927	CcSEcCtD
Haloperidol—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000149	0.000927	CcSEcCtD
Haloperidol—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000148	0.000925	CcSEcCtD
Haloperidol—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000148	0.000923	CcSEcCtD
Haloperidol—Headache—Topotecan—peripheral nervous system neoplasm	0.000148	0.000922	CcSEcCtD
Haloperidol—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000148	0.000921	CcSEcCtD
Haloperidol—Rash—Tretinoin—peripheral nervous system neoplasm	0.000148	0.000921	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000148	0.000921	CcSEcCtD
Haloperidol—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000148	0.00092	CcSEcCtD
Haloperidol—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000147	0.00092	CcSEcCtD
Haloperidol—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000147	0.00092	CcSEcCtD
Haloperidol—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000147	0.000917	CcSEcCtD
Haloperidol—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000147	0.000916	CcSEcCtD
Haloperidol—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000147	0.000916	CcSEcCtD
Haloperidol—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000915	CcSEcCtD
Haloperidol—Headache—Tretinoin—peripheral nervous system neoplasm	0.000147	0.000915	CcSEcCtD
Haloperidol—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000147	0.000915	CcSEcCtD
Haloperidol—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000146	0.000914	CcSEcCtD
Haloperidol—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000146	0.000912	CcSEcCtD
Haloperidol—Constipation—Vincristine—peripheral nervous system neoplasm	0.000146	0.000912	CcSEcCtD
Haloperidol—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000146	0.000912	CcSEcCtD
Haloperidol—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000146	0.00091	CcSEcCtD
Haloperidol—Rash—Melphalan—peripheral nervous system neoplasm	0.000146	0.000909	CcSEcCtD
Haloperidol—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000146	0.000908	CcSEcCtD
Haloperidol—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000144	0.0009	CcSEcCtD
Haloperidol—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000144	0.000899	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000143	0.000895	CcSEcCtD
Haloperidol—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000143	0.00089	CcSEcCtD
Haloperidol—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000141	0.000881	CcSEcCtD
Haloperidol—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.00088	CcSEcCtD
Haloperidol—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000141	0.000879	CcSEcCtD
Haloperidol—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000141	0.000879	CcSEcCtD
Haloperidol—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00014	0.000875	CcSEcCtD
Haloperidol—Nausea—Topotecan—peripheral nervous system neoplasm	0.00014	0.000874	CcSEcCtD
Haloperidol—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00014	0.000871	CcSEcCtD
Haloperidol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000139	0.000867	CcSEcCtD
Haloperidol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000139	0.000867	CcSEcCtD
Haloperidol—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000867	CcSEcCtD
Haloperidol—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000138	0.000864	CcSEcCtD
Haloperidol—Nausea—Melphalan—peripheral nervous system neoplasm	0.000137	0.000856	CcSEcCtD
Haloperidol—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000852	CcSEcCtD
Haloperidol—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000136	0.000846	CcSEcCtD
Haloperidol—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000135	0.000843	CcSEcCtD
Haloperidol—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000135	0.000843	CcSEcCtD
Haloperidol—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000842	CcSEcCtD
Haloperidol—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000135	0.000841	CcSEcCtD
Haloperidol—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000134	0.000839	CcSEcCtD
Haloperidol—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000134	0.00177	CbGeAlD
Haloperidol—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000134	0.000835	CcSEcCtD
Haloperidol—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000833	CcSEcCtD
Haloperidol—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000824	CcSEcCtD
Haloperidol—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000132	0.000823	CcSEcCtD
Haloperidol—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000131	0.00082	CcSEcCtD
Haloperidol—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000131	0.000817	CcSEcCtD
Haloperidol—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000131	0.000815	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00013	0.000814	CcSEcCtD
Haloperidol—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000809	CcSEcCtD
Haloperidol—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000129	0.000807	CcSEcCtD
Haloperidol—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000796	CcSEcCtD
Haloperidol—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000788	CcSEcCtD
Haloperidol—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000126	0.000786	CcSEcCtD
Haloperidol—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000125	0.000783	CcSEcCtD
Haloperidol—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000777	CcSEcCtD
Haloperidol—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000125	0.000777	CcSEcCtD
Haloperidol—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000775	CcSEcCtD
Haloperidol—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000123	0.00077	CcSEcCtD
Haloperidol—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000123	0.00077	CcSEcCtD
Haloperidol—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000768	CcSEcCtD
Haloperidol—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000123	0.000768	CcSEcCtD
Haloperidol—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000122	0.00161	CbGeAlD
Haloperidol—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000759	CcSEcCtD
Haloperidol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000122	0.000759	CcSEcCtD
Haloperidol—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000121	0.000757	CcSEcCtD
Haloperidol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000121	0.000753	CcSEcCtD
Haloperidol—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00012	0.000751	CcSEcCtD
Haloperidol—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000748	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00012	0.000746	CcSEcCtD
Haloperidol—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000119	0.000745	CcSEcCtD
Haloperidol—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000119	0.00074	CcSEcCtD
Haloperidol—Constipation—Etoposide—peripheral nervous system neoplasm	0.000118	0.000739	CcSEcCtD
Haloperidol—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000737	CcSEcCtD
Haloperidol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000117	0.000732	CcSEcCtD
Haloperidol—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000117	0.00073	CcSEcCtD
Haloperidol—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000719	CcSEcCtD
Haloperidol—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000718	CcSEcCtD
Haloperidol—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000717	CcSEcCtD
Haloperidol—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000713	CcSEcCtD
Haloperidol—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000114	0.000712	CcSEcCtD
Haloperidol—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000711	CcSEcCtD
Haloperidol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000114	0.000709	CcSEcCtD
Haloperidol—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000709	CcSEcCtD
Haloperidol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000113	0.000705	CcSEcCtD
Haloperidol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000113	0.000704	CcSEcCtD
Haloperidol—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000703	CcSEcCtD
Haloperidol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000112	0.000698	CcSEcCtD
Haloperidol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000112	0.000697	CcSEcCtD
Haloperidol—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000111	0.000695	CcSEcCtD
Haloperidol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000111	0.000693	CcSEcCtD
Haloperidol—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00011	0.000686	CcSEcCtD
Haloperidol—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000685	CcSEcCtD
Haloperidol—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000109	0.000683	CcSEcCtD
Haloperidol—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000682	CcSEcCtD
Haloperidol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000109	0.000678	CcSEcCtD
Haloperidol—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000673	CcSEcCtD
Haloperidol—Rash—Vincristine—peripheral nervous system neoplasm	0.000108	0.000672	CcSEcCtD
Haloperidol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000108	0.000672	CcSEcCtD
Haloperidol—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000107	0.00067	CcSEcCtD
Haloperidol—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000668	CcSEcCtD
Haloperidol—Headache—Vincristine—peripheral nervous system neoplasm	0.000107	0.000668	CcSEcCtD
Haloperidol—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000664	CcSEcCtD
Haloperidol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000105	0.000657	CcSEcCtD
Haloperidol—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000657	CcSEcCtD
Haloperidol—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000656	CcSEcCtD
Haloperidol—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000103	0.000645	CcSEcCtD
Haloperidol—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000637	CcSEcCtD
Haloperidol—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000102	0.000636	CcSEcCtD
Haloperidol—Nausea—Vincristine—peripheral nervous system neoplasm	0.000102	0.000633	CcSEcCtD
Haloperidol—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000633	CcSEcCtD
Haloperidol—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000631	CcSEcCtD
Haloperidol—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	9.98e-05	0.000623	CcSEcCtD
Haloperidol—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	9.93e-05	0.00062	CcSEcCtD
Haloperidol—Angiopathy—Epirubicin—peripheral nervous system neoplasm	9.91e-05	0.000618	CcSEcCtD
Haloperidol—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	9.91e-05	0.000618	CcSEcCtD
Haloperidol—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	9.87e-05	0.000616	CcSEcCtD
Haloperidol—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	9.85e-05	0.000614	CcSEcCtD
Haloperidol—Pruritus—Etoposide—peripheral nervous system neoplasm	9.8e-05	0.000611	CcSEcCtD
Haloperidol—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	9.74e-05	0.000608	CcSEcCtD
Haloperidol—Alopecia—Epirubicin—peripheral nervous system neoplasm	9.65e-05	0.000602	CcSEcCtD
Haloperidol—Vomiting—Cisplatin—peripheral nervous system neoplasm	9.61e-05	0.0006	CcSEcCtD
Haloperidol—Mental disorder—Epirubicin—peripheral nervous system neoplasm	9.57e-05	0.000597	CcSEcCtD
Haloperidol—Rash—Cisplatin—peripheral nervous system neoplasm	9.53e-05	0.000595	CcSEcCtD
Haloperidol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	9.52e-05	0.000594	CcSEcCtD
Haloperidol—Malnutrition—Epirubicin—peripheral nervous system neoplasm	9.51e-05	0.000593	CcSEcCtD
Haloperidol—Diarrhoea—Etoposide—peripheral nervous system neoplasm	9.47e-05	0.000591	CcSEcCtD
Haloperidol—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	9.45e-05	0.000589	CcSEcCtD
Haloperidol—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	9.38e-05	0.000585	CcSEcCtD
Haloperidol—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	9.17e-05	0.000572	CcSEcCtD
Haloperidol—Dizziness—Etoposide—peripheral nervous system neoplasm	9.16e-05	0.000571	CcSEcCtD
Haloperidol—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	9.14e-05	0.00057	CcSEcCtD
Haloperidol—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	9.13e-05	0.00057	CcSEcCtD
Haloperidol—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	9.11e-05	0.000568	CcSEcCtD
Haloperidol—Nausea—Cisplatin—peripheral nervous system neoplasm	8.98e-05	0.00056	CcSEcCtD
Haloperidol—Vision blurred—Epirubicin—peripheral nervous system neoplasm	8.96e-05	0.000559	CcSEcCtD
Haloperidol—Alopecia—Doxorubicin—peripheral nervous system neoplasm	8.93e-05	0.000557	CcSEcCtD
Haloperidol—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	8.86e-05	0.000553	CcSEcCtD
Haloperidol—Vomiting—Etoposide—peripheral nervous system neoplasm	8.8e-05	0.000549	CcSEcCtD
Haloperidol—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	8.8e-05	0.000549	CcSEcCtD
Haloperidol—Anaemia—Epirubicin—peripheral nervous system neoplasm	8.79e-05	0.000548	CcSEcCtD
Haloperidol—ABCB1—cerebellum—peripheral nervous system neoplasm	8.78e-05	0.00116	CbGeAlD
Haloperidol—Agitation—Epirubicin—peripheral nervous system neoplasm	8.74e-05	0.000545	CcSEcCtD
Haloperidol—Rash—Etoposide—peripheral nervous system neoplasm	8.73e-05	0.000545	CcSEcCtD
Haloperidol—Dermatitis—Etoposide—peripheral nervous system neoplasm	8.72e-05	0.000544	CcSEcCtD
Haloperidol—Headache—Etoposide—peripheral nervous system neoplasm	8.67e-05	0.000541	CcSEcCtD
Haloperidol—Vertigo—Epirubicin—peripheral nervous system neoplasm	8.54e-05	0.000533	CcSEcCtD
Haloperidol—Leukopenia—Epirubicin—peripheral nervous system neoplasm	8.51e-05	0.000531	CcSEcCtD
Haloperidol—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	8.46e-05	0.000528	CcSEcCtD
Haloperidol—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	8.29e-05	0.000517	CcSEcCtD
Haloperidol—Convulsion—Epirubicin—peripheral nervous system neoplasm	8.24e-05	0.000514	CcSEcCtD
Haloperidol—Nausea—Etoposide—peripheral nervous system neoplasm	8.22e-05	0.000513	CcSEcCtD
Haloperidol—Hypertension—Epirubicin—peripheral nervous system neoplasm	8.21e-05	0.000512	CcSEcCtD
Haloperidol—Anaemia—Doxorubicin—peripheral nervous system neoplasm	8.13e-05	0.000507	CcSEcCtD
Haloperidol—Agitation—Doxorubicin—peripheral nervous system neoplasm	8.09e-05	0.000504	CcSEcCtD
Haloperidol—Anxiety—Epirubicin—peripheral nervous system neoplasm	8.07e-05	0.000503	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	8.04e-05	0.000502	CcSEcCtD
Haloperidol—Dry mouth—Epirubicin—peripheral nervous system neoplasm	7.92e-05	0.000494	CcSEcCtD
Haloperidol—Vertigo—Doxorubicin—peripheral nervous system neoplasm	7.91e-05	0.000493	CcSEcCtD
Haloperidol—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	7.88e-05	0.000491	CcSEcCtD
Haloperidol—Confusional state—Epirubicin—peripheral nervous system neoplasm	7.83e-05	0.000488	CcSEcCtD
Haloperidol—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	7.76e-05	0.000484	CcSEcCtD
Haloperidol—Oedema—Epirubicin—peripheral nervous system neoplasm	7.76e-05	0.000484	CcSEcCtD
Haloperidol—Convulsion—Doxorubicin—peripheral nervous system neoplasm	7.62e-05	0.000476	CcSEcCtD
Haloperidol—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	7.61e-05	0.000475	CcSEcCtD
Haloperidol—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	7.6e-05	0.000474	CcSEcCtD
Haloperidol—Hypertension—Doxorubicin—peripheral nervous system neoplasm	7.6e-05	0.000474	CcSEcCtD
Haloperidol—Tachycardia—Epirubicin—peripheral nervous system neoplasm	7.57e-05	0.000473	CcSEcCtD
Haloperidol—Skin disorder—Epirubicin—peripheral nervous system neoplasm	7.54e-05	0.00047	CcSEcCtD
Haloperidol—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	7.5e-05	0.000468	CcSEcCtD
Haloperidol—Anxiety—Doxorubicin—peripheral nervous system neoplasm	7.47e-05	0.000466	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	7.44e-05	0.000464	CcSEcCtD
Haloperidol—Anorexia—Epirubicin—peripheral nervous system neoplasm	7.4e-05	0.000462	CcSEcCtD
Haloperidol—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	7.33e-05	0.000457	CcSEcCtD
Haloperidol—Hypotension—Epirubicin—peripheral nervous system neoplasm	7.25e-05	0.000452	CcSEcCtD
Haloperidol—Confusional state—Doxorubicin—peripheral nervous system neoplasm	7.24e-05	0.000452	CcSEcCtD
Haloperidol—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	7.18e-05	0.000448	CcSEcCtD
Haloperidol—Oedema—Doxorubicin—peripheral nervous system neoplasm	7.18e-05	0.000448	CcSEcCtD
Haloperidol—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	7.04e-05	0.000439	CcSEcCtD
Haloperidol—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	7.03e-05	0.000439	CcSEcCtD
Haloperidol—Insomnia—Epirubicin—peripheral nervous system neoplasm	7.02e-05	0.000438	CcSEcCtD
Haloperidol—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	7.01e-05	0.000437	CcSEcCtD
Haloperidol—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	6.98e-05	0.000435	CcSEcCtD
Haloperidol—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	6.94e-05	0.000433	CcSEcCtD
Haloperidol—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	6.92e-05	0.000432	CcSEcCtD
Haloperidol—Somnolence—Epirubicin—peripheral nervous system neoplasm	6.9e-05	0.00043	CcSEcCtD
Haloperidol—Anorexia—Doxorubicin—peripheral nervous system neoplasm	6.85e-05	0.000427	CcSEcCtD
Haloperidol—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	6.83e-05	0.000426	CcSEcCtD
Haloperidol—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	6.75e-05	0.000421	CcSEcCtD
Haloperidol—Hypotension—Doxorubicin—peripheral nervous system neoplasm	6.71e-05	0.000419	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	6.7e-05	0.000418	CcSEcCtD
Haloperidol—Constipation—Epirubicin—peripheral nervous system neoplasm	6.64e-05	0.000414	CcSEcCtD
Haloperidol—Insomnia—Doxorubicin—peripheral nervous system neoplasm	6.5e-05	0.000405	CcSEcCtD
Haloperidol—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	6.4e-05	0.000399	CcSEcCtD
Haloperidol—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	6.4e-05	0.000399	CcSEcCtD
Haloperidol—Somnolence—Doxorubicin—peripheral nervous system neoplasm	6.38e-05	0.000398	CcSEcCtD
Haloperidol—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	6.32e-05	0.000394	CcSEcCtD
Haloperidol—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	6.24e-05	0.000389	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	6.2e-05	0.000387	CcSEcCtD
Haloperidol—Urticaria—Epirubicin—peripheral nervous system neoplasm	6.17e-05	0.000385	CcSEcCtD
Haloperidol—Constipation—Doxorubicin—peripheral nervous system neoplasm	6.14e-05	0.000383	CcSEcCtD
Haloperidol—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	6.14e-05	0.000383	CcSEcCtD
Haloperidol—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	5.92e-05	0.000369	CcSEcCtD
Haloperidol—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	5.72e-05	0.000357	CcSEcCtD
Haloperidol—Urticaria—Doxorubicin—peripheral nervous system neoplasm	5.7e-05	0.000356	CcSEcCtD
Haloperidol—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.000354	CcSEcCtD
Haloperidol—Pruritus—Epirubicin—peripheral nervous system neoplasm	5.49e-05	0.000343	CcSEcCtD
Haloperidol—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	5.31e-05	0.000331	CcSEcCtD
Haloperidol—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	5.29e-05	0.00033	CcSEcCtD
Haloperidol—Dizziness—Epirubicin—peripheral nervous system neoplasm	5.13e-05	0.00032	CcSEcCtD
Haloperidol—Pruritus—Doxorubicin—peripheral nervous system neoplasm	5.08e-05	0.000317	CcSEcCtD
Haloperidol—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.93e-05	0.000308	CcSEcCtD
Haloperidol—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.91e-05	0.000307	CcSEcCtD
Haloperidol—Rash—Epirubicin—peripheral nervous system neoplasm	4.89e-05	0.000305	CcSEcCtD
Haloperidol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.89e-05	0.000305	CcSEcCtD
Haloperidol—Headache—Epirubicin—peripheral nervous system neoplasm	4.86e-05	0.000303	CcSEcCtD
Haloperidol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.75e-05	0.000296	CcSEcCtD
Haloperidol—Nausea—Epirubicin—peripheral nervous system neoplasm	4.61e-05	0.000288	CcSEcCtD
Haloperidol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	4.57e-05	0.000285	CcSEcCtD
Haloperidol—Rash—Doxorubicin—peripheral nervous system neoplasm	4.53e-05	0.000283	CcSEcCtD
Haloperidol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	4.52e-05	0.000282	CcSEcCtD
Haloperidol—Headache—Doxorubicin—peripheral nervous system neoplasm	4.5e-05	0.000281	CcSEcCtD
Haloperidol—Nausea—Doxorubicin—peripheral nervous system neoplasm	4.27e-05	0.000266	CcSEcCtD
Haloperidol—HTR2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.52e-05	0.000359	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.51e-05	0.000357	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.5e-05	0.000354	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.49e-05	0.000351	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.48e-05	0.00035	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.46e-05	0.000346	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.46e-05	0.000344	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.44e-05	0.000341	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.44e-05	0.000341	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	1.44e-05	0.00034	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.44e-05	0.000339	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	1.43e-05	0.000338	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.43e-05	0.000337	CbGpPWpGaD
Haloperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.43e-05	0.000337	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.43e-05	0.000337	CbGpPWpGaD
Haloperidol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.42e-05	0.000336	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.42e-05	0.000335	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.42e-05	0.000334	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.42e-05	0.000334	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.42e-05	0.000334	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.41e-05	0.000333	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.4e-05	0.000331	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.4e-05	0.000331	CbGpPWpGaD
Haloperidol—GRIN2B—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.4e-05	0.00033	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.39e-05	0.000327	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	1.38e-05	0.000326	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.37e-05	0.000324	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.37e-05	0.000323	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.37e-05	0.000323	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.36e-05	0.000322	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.35e-05	0.000319	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.35e-05	0.000318	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	1.35e-05	0.000318	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.35e-05	0.000318	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.34e-05	0.000316	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	1.33e-05	0.000314	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.32e-05	0.000312	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.32e-05	0.000311	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—GNAS—peripheral nervous system neoplasm	1.31e-05	0.000309	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.3e-05	0.000307	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.3e-05	0.000307	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.3e-05	0.000307	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—ABCB1—peripheral nervous system neoplasm	1.28e-05	0.000303	CbGpPWpGaD
Haloperidol—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.28e-05	0.000302	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.26e-05	0.000298	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.26e-05	0.000297	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.25e-05	0.000294	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.24e-05	0.000293	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.24e-05	0.000292	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.23e-05	0.00029	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	1.23e-05	0.000289	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	1.22e-05	0.000288	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.21e-05	0.000286	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.21e-05	0.000286	CbGpPWpGaD
Haloperidol—EBP—Metabolism—AKT1—peripheral nervous system neoplasm	1.19e-05	0.000282	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.19e-05	0.000282	CbGpPWpGaD
Haloperidol—CBR1—Metabolism—AKT1—peripheral nervous system neoplasm	1.17e-05	0.000277	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.17e-05	0.000276	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	1.17e-05	0.000276	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.16e-05	0.000273	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.15e-05	0.000273	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.14e-05	0.000269	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	1.13e-05	0.000266	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	1.1e-05	0.00026	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.08e-05	0.000256	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	1.08e-05	0.000255	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.07e-05	0.000253	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.07e-05	0.000252	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.06e-05	0.000251	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.06e-05	0.00025	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	1.04e-05	0.000245	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.03e-05	0.000244	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.89e-06	0.000233	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—BCHE—peripheral nervous system neoplasm	9.79e-06	0.000231	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	9.74e-06	0.00023	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	9.54e-06	0.000225	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	9.48e-06	0.000224	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	9.41e-06	0.000222	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	9.39e-06	0.000222	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	9.37e-06	0.000221	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.34e-06	0.00022	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	9.27e-06	0.000219	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	9.26e-06	0.000218	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—TH—peripheral nervous system neoplasm	9.21e-06	0.000217	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	9.12e-06	0.000215	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	9.1e-06	0.000215	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	9.02e-06	0.000213	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.84e-06	0.000209	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.76e-06	0.000207	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	8.72e-06	0.000206	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	8.71e-06	0.000206	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.7e-06	0.000205	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	8.69e-06	0.000205	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.68e-06	0.000205	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	8.65e-06	0.000204	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.6e-06	0.000203	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.58e-06	0.000202	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.44e-06	0.000199	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.42e-06	0.000199	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.29e-06	0.000196	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	8.11e-06	0.000191	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.06e-06	0.00019	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	8.01e-06	0.000189	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.98e-06	0.000188	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.96e-06	0.000188	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	7.95e-06	0.000188	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.91e-06	0.000187	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	7.82e-06	0.000185	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	7.81e-06	0.000184	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.64e-06	0.00018	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.6e-06	0.000179	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	7.53e-06	0.000178	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—GNAS—peripheral nervous system neoplasm	7.52e-06	0.000177	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.5e-06	0.000177	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.46e-06	0.000176	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.46e-06	0.000176	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	7.39e-06	0.000174	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	7.37e-06	0.000174	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	7.37e-06	0.000174	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.36e-06	0.000174	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	7.35e-06	0.000174	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	7.31e-06	0.000172	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.03e-06	0.000166	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.97e-06	0.000164	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	6.93e-06	0.000164	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	6.87e-06	0.000162	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.8e-06	0.00016	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.66e-06	0.000157	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.55e-06	0.000155	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.41e-06	0.000151	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.27e-06	0.000148	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.25e-06	0.000148	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	6.24e-06	0.000147	CbGpPWpGaD
Haloperidol—HTR1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.23e-06	0.000147	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.17e-06	0.000146	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.17e-06	0.000146	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	6.15e-06	0.000145	CbGpPWpGaD
Haloperidol—HTR1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.1e-06	0.000144	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.04e-06	0.000143	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	6.03e-06	0.000142	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	6e-06	0.000142	CbGpPWpGaD
Haloperidol—DRD4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6e-06	0.000142	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.96e-06	0.000141	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.95e-06	0.00014	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.9e-06	0.000139	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.89e-06	0.000139	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	5.87e-06	0.000139	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.82e-06	0.000137	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.74e-06	0.000135	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.73e-06	0.000135	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	5.7e-06	0.000135	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.68e-06	0.000134	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.66e-06	0.000134	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	5.66e-06	0.000134	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.64e-06	0.000133	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.63e-06	0.000133	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.63e-06	0.000133	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	5.61e-06	0.000132	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.56e-06	0.000131	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	5.55e-06	0.000131	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.54e-06	0.000131	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.54e-06	0.000131	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.53e-06	0.000131	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	5.5e-06	0.00013	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.48e-06	0.000129	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.45e-06	0.000129	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.4e-06	0.000128	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.35e-06	0.000126	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.33e-06	0.000126	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.28e-06	0.000125	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.2e-06	0.000123	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.17e-06	0.000122	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.07e-06	0.00012	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.98e-06	0.000118	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.91e-06	0.000116	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.84e-06	0.000114	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.82e-06	0.000114	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	4.82e-06	0.000114	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	4.79e-06	0.000113	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.76e-06	0.000112	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.72e-06	0.000111	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.7e-06	0.000111	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.64e-06	0.00011	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.6e-06	0.000108	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	4.53e-06	0.000107	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.49e-06	0.000106	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.45e-06	0.000105	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.43e-06	0.000105	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.43e-06	0.000105	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.38e-06	0.000103	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.37e-06	0.000103	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.2e-06	9.9e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.18e-06	9.87e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.13e-06	9.74e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.12e-06	9.73e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.12e-06	9.72e-05	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.08e-06	9.63e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.04e-06	9.54e-05	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.01e-06	9.47e-05	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.01e-06	9.45e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.98e-06	9.39e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.97e-06	9.37e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.96e-06	9.34e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.87e-06	9.15e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.81e-06	9e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.78e-06	8.93e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.71e-06	8.75e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.7e-06	8.74e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.7e-06	8.73e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.65e-06	8.61e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.65e-06	8.6e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.64e-06	8.59e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.64e-06	8.59e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	3.63e-06	8.56e-05	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—AKT1—peripheral nervous system neoplasm	3.53e-06	8.34e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.48e-06	8.22e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.43e-06	8.1e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.39e-06	8e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.39e-06	7.99e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.34e-06	7.89e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.33e-06	7.87e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.33e-06	7.85e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.28e-06	7.75e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.27e-06	7.72e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.24e-06	7.65e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.22e-06	7.6e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.16e-06	7.45e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.11e-06	7.33e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.1e-06	7.31e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.07e-06	7.25e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	2.97e-06	7.01e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.9e-06	6.84e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.86e-06	6.75e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.59e-06	6.12e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.55e-06	6.02e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.54e-06	6.01e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.48e-06	5.85e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.44e-06	5.76e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.43e-06	5.74e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.19e-06	5.17e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.15e-06	5.08e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.15e-06	5.07e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	2.15e-06	5.07e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.03e-06	4.79e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.66e-06	3.92e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.62e-06	3.82e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.53e-06	3.6e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.51e-06	3.57e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.29e-06	3.05e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	9.98e-07	2.36e-05	CbGpPWpGaD
